NYSE:NHINational Health Investors Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding National Health Investors Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $57.02 +0.32 (+0.56 %) (As of 06/2/2020 10:16 AM ET) Add Compare Share Today's Range$56.80Now: $57.02▼$57.5050-Day Range$46.74MA: $52.74▼$58.7952-Week Range$31.37Now: $57.02▼$91.12Volume348 shsAverage Volume360,865 shsMarket Capitalization$2.55 billionP/E Ratio13.54Dividend Yield7.95%Beta0.84 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.Read More Beat the Market (BTM) Rank™ 2.0 Analyst's Opinion Consensus RatingNational Health Investors has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $63.83, National Health Investors has a potential upside of 11.9% from its current price of $57.02.Amount of Analyst CoverageNational Health Investors has only been the subject of 4 research reports in the past 90 days. Previous Next 2.2 Community Rank Outperform VotesNational Health Investors has received 324 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNational Health Investors has received 429 “underperform” votes. (Add your “underperform” vote.)Community SentimentNational Health Investors has received 56.97% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about National Health Investors and other stocks. Vote “Outperform” if you believe NHI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NHI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 3.3 Dividend Strength Dividend LeadershipNational Health Investors is a leading dividend payer. It pays a dividend yield of 7.95%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNational Health Investors has been increasing its dividend for 10 years.Dividend CoverageThe dividend payout ratio of National Health Investors is 80.18 %. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, National Health Investors will have a dividend payout ratio of 79.32 % in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Health Investors insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,096,421.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 5.74% of the stock of National Health Investors is held by insiders.Percentage Held by Institutions68.95% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for National Health Investors are expected to decrease by -0.89% in the coming year, from $5.61 to $5.56 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Health Investors is 13.54, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 15.66.Price to Earnings Ratio vs. SectorThe P/E ratio of National Health Investors is 13.54, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 18.97.Price to Book Value per Share RatioNational Health Investors has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.0Community Rank: 2.2Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.56 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance Current SymbolNYSE:NHI Previous Symbol CUSIP63633D10 CIK877860 Webwww.nhireit.com Phone615-890-9100Debt Debt-to-Equity Ratio1.03 Current Ratio12.05 Quick Ratio12.05Price-To-Earnings Trailing P/E Ratio13.54 Forward P/E Ratio10.16 P/E GrowthN/A Sales & Book Value Annual Sales$318.08 million Price / Sales8.00 Cash Flow$5.67 per share Price / Cash Flow10.05 Book Value$34.08 per share Price / Book1.67Profitability EPS (Most Recent Fiscal Year)$5.50 Net Income$160.46 million Net Margins57.16% Return on Equity12.62% Return on Assets6.08%Miscellaneous Employees16 Outstanding Shares44,650,000Market Cap$2.55 billion Next Earnings Date8/13/2020 (Estimated) OptionableOptionable NHI Rates by TradingView Receive NHI News and Ratings via Email Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter. National Health Investors (NYSE:NHI) Frequently Asked Questions How has National Health Investors' stock been impacted by COVID-19 (Coronavirus)? National Health Investors' stock was trading at $70.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NHI stock has decreased by 19.5% and is now trading at $57.02. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of National Health Investors? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for National Health Investors. When is National Health Investors' next earnings date? National Health Investors is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for National Health Investors. How were National Health Investors' earnings last quarter? National Health Investors Inc (NYSE:NHI) released its quarterly earnings results on Monday, May, 11th. The real estate investment trust reported $1.37 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.40 by $0.03. The real estate investment trust had revenue of $83.08 million for the quarter, compared to analysts' expectations of $80.77 million. National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. The firm's revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 EPS. View National Health Investors' earnings history. How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors? National Health Investors declared a quarterly dividend on Thursday, February 20th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $1.1025 per share on Friday, May 8th. This represents a $4.41 dividend on an annualized basis and a dividend yield of 7.73%. The ex-dividend date is Monday, March 30th. This is a boost from National Health Investors's previous quarterly dividend of $1.05. View National Health Investors' dividend history. What price target have analysts set for NHI? 6 Wall Street analysts have issued 1-year target prices for National Health Investors' stock. Their forecasts range from $40.00 to $94.00. On average, they anticipate National Health Investors' share price to reach $63.83 in the next year. This suggests a possible upside of 11.9% from the stock's current price. View analysts' price targets for National Health Investors. Has National Health Investors been receiving favorable news coverage? Media headlines about NHI stock have been trending very positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. National Health Investors earned a media sentiment score of 3.5 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutNational Health Investors. Are investors shorting National Health Investors? National Health Investors saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,510,000 shares, an increase of 6.3% from the April 30th total of 1,420,000 shares. Based on an average trading volume of 463,200 shares, the days-to-cover ratio is currently 3.3 days. Approximately 3.6% of the company's shares are short sold. View National Health Investors' Current Options Chain. Who are some of National Health Investors' key competitors? Some companies that are related to National Health Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Ventas (VTR), Extra Space Storage (EXR), HCP (HCP), Medical Properties Trust (MPW), Host Hotels and Resorts (HST), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), Healthcare Realty Trust (HR), Rayonier (RYN) and Sabra Health Care REIT (SBRA). View all competitors. What other stocks do shareholders of National Health Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), ANNALY CAP MGMT/SH (NLY), Energy Transfer LP Unit (ET), Cisco Systems (CSCO), AbbVie (ABBV), Realty Income (O), Omega Healthcare Investors (OHI), Broadcom (AVGO), EPR Properties (EPR) and Simon Property Group (SPG). Who are National Health Investors' key executives? National Health Investors' management team includes the following people: Mr. D. Eric Mendelsohn, Pres & CEO (Age 57)Mr. John L. Spaid, Exec. VP of Fin. (Age 59)Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 38)Mr. Roger R. Hopkins, Chief Accounting Officer (Age 57)Ms. Colleen Schaller, Director, Investor Relations What is National Health Investors' stock symbol? National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI." Who are National Health Investors' major shareholders? National Health Investors' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.38%), State Street Corp (3.55%), JPMorgan Chase & Co. (2.35%), Bank of New York Mellon Corp (2.02%), Geode Capital Management LLC (1.46%) and Principal Financial Group Inc. (1.20%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Kristin Sallee Gaines, Robert A Mccabe Jr, Robert A Mccabe, Jr, Robert G Adams, Robert T Webb and W Andrew Adams. View institutional ownership trends for National Health Investors. Which institutional investors are selling National Health Investors stock? NHI stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., Public Employees Retirement Association of Colorado, Principal Financial Group Inc., WINTON GROUP Ltd, UBS Group AG, Virtus ETF Advisers LLC, and Wealth Quarterback LLC. Company insiders that have sold National Health Investors company stock in the last year include D Eric Mendelsohn, James R Jobe, and Kevin Carlton Pascoe. View insider buying and selling activity for National Health Investors. Which institutional investors are buying National Health Investors stock? NHI stock was purchased by a variety of institutional investors in the last quarter, including M Holdings Securities Inc., Bank of New York Mellon Corp, State Street Corp, GW&K Investment Management LLC, Monarch Partners Asset Management LLC, Two Sigma Advisers LP, Canada Pension Plan Investment Board, and JPMorgan Chase & Co.. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams. View insider buying and selling activity for National Health Investors. How do I buy shares of National Health Investors? Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is National Health Investors' stock price today? One share of NHI stock can currently be purchased for approximately $57.02. How big of a company is National Health Investors? National Health Investors has a market capitalization of $2.55 billion and generates $318.08 million in revenue each year. The real estate investment trust earns $160.46 million in net income (profit) each year or $5.50 on an earnings per share basis. National Health Investors employs 16 workers across the globe. What is National Health Investors' official website? The official website for National Health Investors is www.nhireit.com. How can I contact National Health Investors? National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected] This page was last updated on 6/2/2020 by MarketBeat.com Staff
